Close

Analyst Ratings for Coherus Biosciences (CHRS)

CHRS Rating Summary

CHRS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CHRS
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $13.67 (+58%) * Over Last 12-Mos
Rating Score: 7.5 / 10   Percentile Rank: 79%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/14/2022 UBS
» Updated 9/16/2022
Ashwani Verma New Coverage Neutral
(N/A)
11.00
(7.00)
6.72
(8.65)
28.72% Details
3/7/2022 JPMorgan
» Updated 12/16/2022
Chris Schott Downgrade Neutral
(Overweight)
9.00
(11.00)
11.56
(8.65)
-25.17% Details
Like CHRS Ratings? Also take a look at HMN, ALLE, DIBS

CHRS Ratings News